Alpha-V/Beta-3 and Alpha-V/Beta-5 Integrin distribution in neoplastic kidney

American Journal of Nephrology

Volumn 16, Issue 5, 1996, Pages 402-408

  Rabb, Hamid ^a   Barroso Vicens, Elvira ^a   Adams, Richard ^a   Pow Sang, Julio ^a,b   Ramirez, German ^a  

^a Div of Nephrology and Hypertension   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cancer; Integrins; Kidney; Osteopontin; Tubules; Vitronectin

Indexed keywords

GLYCOPROTEIN; INTEGRIN; MONOCLONAL ANTIBODY; OSTEOPONTIN; PROTEIN SUBUNIT; RECEPTOR; VITRONECTIN;

ANGIOGENESIS; ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; GLOMERULUS EPITHELIUM; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY TUBULE EPITHELIUM; MESANGIUM; METASTASIS; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 0029846918     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169032     Document Type: Article

References (37)

1. Ruoslahti E: lntegrins. J Clin Invest 1991:87: 1-5.
2. Hynes RO: lntegrins: A family of cell surface receptors. Cell 1985:48:549-554.
3. Springer TA: Adhesion receptors of the immune system. Nature 1990:346:425-434.
4. Ginsberg MH, Loftus JC, Plow EF: Cytoadhe-sions. integrins and platelets. Thromb Haemost 1988:59:1-6.
5. v gene expression in human melanomatumo-rigenicity. J Clin Invest 1992:89:2018-2022.
6. Wayner EA, Carter WG: Identification of multiple cell adhesion receptors for type IV collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol 1987; 105:1873-1884.
7. Cheresh DA, Smith JW, Cooper HM, Quaranta V: A novel vitronectin receptor integrin (ctvß,) is responsible for distinct adhesive properties of carcinoma cells. Cell 1989:58:945-953.
8. vßi). J Biol Chem 1990;265:5934-5937.
9. Eliccs MJ, Hentler ME: The human integrin VLA-2 is collagen receptor on some cells and collagcn/laminin receptor on others. Proc Natl Acad Sei USA 1989:86:9906-9910.
10. Kcrjaschi D, Ohja PP, Susani M, Horvat R, Binder S, Hovorka A, Hillemanns P, Pytela R: A ßi integrin receptor for fibronectin in human kidney glomeruli. Am J Pathol 1989:134:481-489.
11. Korhonen M, Ylanne J, Laitinen L, Virtanen I: The subunits of integrins are characteristically expressed on distinct segments of developing and adult human nephron. J Cell Biol 1990;111:1245-1254.
12. Korhonen M, Ylanne J, Laitinen L, Virtanen I: Distribution of ßi and ßj integrins in human fetal and adult kidney. Lab Invest 1990:62: 616-623.
13. Korhonen M, Laitinen L, Ylanne J, Gould VE: Virtanen I: lntegrins in developing, normal and malignant human kidney. Kidney Int 1992:41: 641-644.
14. Lopez CA, Hover HR, Wilson PD, Waterhouse P, Denhardt DT: Heterogeneity ofosteopontin expression among nephrons in mouse kidneys and enhance expression in sclerotic glomeruli. Lab Invest 1993:69:355-363.
15. Rabb HA: Cell adhesion molecules and the kidney. Am J Kidney Dis 1994:23:1-12.
16. Adler S: Integrin receptors in the glomerulus: Potential role in glomerular injury. Am J Physiol 1992;262:F697-F704.
17. Dedhar S, Saulnier R: Alterations in integrin receptor expression on chemically transformed human cells: Specific enhancement of laminin and collagen receptor complexes. J Cell Biol 1990;110:481-489.
18. Zutter MM, Mazoujian G, Santoro SA: Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol 1990;137:863-870.
19. Chan BMC, Matsuura N, Takada Y, Zetter BR, Hemler ME: In vitro and in vivo consequence of VLA-2 expression on rhabdomyosarcoma cells. Science 1991 ;251:1600-1602.
20. Skinner DG, Colvin RB, Vermillion CD, Pfis-ler RC, Leadbetter WF: Diagnosis and management of renal cell carcinoma. Carcinoma 1971;28:1165-1177.
21. Kashgarcan M, Rosai J: Urinary tract: in Rosai J (ed): Ackerman's Surgical Pathology. St. Louis, Mosby, 1989. pp 869-880.
22. Terpe HJ, Tajrobehkar K, Gunthert U, Alta-mannsberger M: Expression of cell adhesion molecules alpha-2, alpha-5, and alpha-6 intc-grins, E-cadhcrin N-CAM and CD-44 in renal cell carcinomas. Virchows Arch A Pathol Anat Histopathol 1993:422:219-224.
23. Korhonen M, Laitinen L, Ylanne LJ, Koukou-lis GK, Quaranta V, Juusela H, Gould VE, Vitanen I: Integrin distributions in renal cell carcinomas of various grades of malignancy. Am J Pathol 1992;141:1161-1171.
24. Chcresh DA, Spiro RC: Biosynthetic and functional properties of an Arg-Gly-Asp-dirccted receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von-Willcbrand factor. J Biol Chem 1987;262: 17703-17711.
25. Bodary SC, McLean JW: The integrin Pi subunit associates with the vitronectin receptor a, subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem 1990;265:5938-5941.
26. Moyle M, Napier MA, McLean JW: Cloning and expression of a divergent integrin subunit Ps. J Biol Chem 1991 ;266:19650-19658.
27. Smith JW, Vestal DJ, Irwin SV, Burke TA, Cheresh DA: Purification and functional characterization of integrin dvps. J Biol Chem 1990; 265:11008-11013.
28. Falcicni R, Cimino L, Gentileschi MP, D’Ag-nano I, Zupi G, Kennel SJ, Sacchi A: Expression of beta 1, beta 3, beta 4, and beta 5 integrals by human lung carcinoma cells of different histotypes. Exp Cell Res 1994:201:113-122.
29. Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA: Requirement of the integrin pj subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 1992:117:1101-1107.
30. vp j for angiogenesis. Science 1994:264:569-571.
31. Hemler ME, Sanchez-Madrid F, Flotte TJ, Krensky AM, Burakoff SJ, Bhan AK: Springer TA. Strominger JL: Glycoproteins of 210.00 and 130.00 m.w. on activated T cells: Cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol 1984;132:3011-3018.
32. Hemler ME, Wark CF, Strominger JL: Characterization of a novel differentiation antigen complex recognized by a monoclonal antibody (A-1A5): Unique activation-specific molecular forms on stimulated T-cells. J Immunol 1983; 131:334-340.
33. Thoenes W, Storkel ST, Rumpelt HJ: Histopa-thology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). Pathol ResPract 1986;181:125-143.
34. vps and u, Ps contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol 1991:113:919-929.
35. Chiraga H, Min W, Van Dusen WJ, Clavman MD, Miner D, Terrell CH, Shcrbotie JR. Foreman JW, Przysiecki C, Neilson EG, Hoyer JR: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 1992;89:426-430.
36. vpi potentiate bone resorption. J Biol Chem 1993;268:9901-9907.
37. Giachelli CM, Bae N, Almeida M, Dendhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointinta formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993:92: 1686-1696.